These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25283522)

  • 1. Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration.
    Toublanc N; Okagaki T; Boyce M; Chan R; Mugitani A; Watanabe S; Yamamoto K; Yoshida K; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):461-9. PubMed ID: 25283522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects.
    Toublanc N; Du X; Liu Y; Chen Q; Singh P; Chan R; Stockis A
    Clin Drug Investig; 2015 Aug; 35(8):495-503. PubMed ID: 26135593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence study of the antiepileptic drug levetiracetam in concentrated solution for injection versus oral tablets in healthy Chinese subjects under fasting conditions: A randomized, open-label, three-way crossover study
.
    Xu J; Zhao X; Wang Z; Zhou Y; Yang X; Cui Y
    Int J Clin Pharmacol Ther; 2018 Nov; 56(11):555-561. PubMed ID: 30168416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
    Wang M; Wang M; Zhang Q; Zong S; Lv C
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities.
    Toublanc N; Lacroix BD; Yamamoto J
    Drug Metab Pharmacokinet; 2014; 29(1):61-8. PubMed ID: 23877106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
    Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A
    Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers.
    Lins RL; Otoul C; De Smedt F; Coupez R; Stockis A
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):47-54. PubMed ID: 17256450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers.
    Levy RH; Ragueneau-Majlessi I; Baltes E
    Epilepsy Res; 2001 Aug; 46(2):93-9. PubMed ID: 11463510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects.
    Zhao Q; Jiang J; Li X; Lu ZS; Hu P
    Br J Clin Pharmacol; 2007 May; 63(5):614-7. PubMed ID: 17324224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men.
    Warrington S; Nagakawa S; Hounslow N
    Clin Drug Investig; 2011 Oct; 31(10):735-43. PubMed ID: 21877766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of two formulations of levetiracetam.
    Franco Spínola AC; Almeida S; Filipe A; Neves RI; Tanguay M; Yritia M
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):591-6. PubMed ID: 19000558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions.
    Boudriau S; Hanzel C; Massicotte J; Sayegh L; Wang J; Lefebvre M
    Drugs R D; 2016 Jun; 16(2):229-38. PubMed ID: 27028750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
    Ragueneau-Majlessi I; Levy RH; Meyerhoff C
    Epilepsy Res; 2001 Nov; 47(1-2):55-63. PubMed ID: 11673021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
    Coupez R; Nicolas JM; Browne TR
    Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers.
    Kumar S; Monif T; Khuroo A; Reyar S; Jain R; Singla AK; Kurachi K
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):39-54. PubMed ID: 24290414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.